EyeWorld Asia-Pacific March 2015 Issue

40 EWAP CATARACT/IOL March 2015 Latest- from page 39 addition to having three points of focus, the lens offers pupil- dependent focusing—the lens increases the light available for distance vision in mesopic conditions, reducing glare and halos. A toric version has been released recently, Dr. Gatinel said, that will have a diffractive face on the front surface of the lens and a toric face on the back surface. Simonetta Morselli, MD , chief of the ophthalmic unit, San Bassiano Hospital, Bassano del Grappa, Italy, discussed new and evolving lenses for microincisional cataract surgery (MICS). One such lens is the INCISE IOL (Bausch + Lomb, B+L, Bridgewater, NJ), a 1-piece posterior chamber IOL made of an enhanced hydrophilic acrylic material. The INCISE lens utilizes advanced optics (AO) technology, Dr. Morselli said, that makes it free from spherical aberrations, less sensitive to tilt, and gives it an enhanced depth of field. The lens uses the same hydrophilic HEMA and hydrophobic PMMA used in B+L’s Akreos AO lens, but includes more of the hydrophobic monomer, making it more stiff and resistant to tearing, Dr. Morselli said. The INCISE lens is inserted using a dedicated injector optimized for 1.8-mm MICS incisions. IOL performance during implantation and placement was controlled and predictable, Dr. Morselli said, and the IOL demonstrated predictable and stable centration at 1–2 months postop. In addition, the posterior capsule remained clear in all cases after 2 years of follow-up. Enhancing premium outcomes D. Ramamurthy, MD , chair of The Eye Foundation, Coimbatore, India, shifted the discussion from new technologies to ways that physicians can enhance outcomes with premium IOL patients. “It is not the IOL that is premium, it is the procedure that is premium,” he said. Achieving good outcomes comes down to the “garbage in, garbage out” principle, Dr. Ramamurthy said—if the primary IOL power calculation is not accurate, there is no way to achieve a satisfactory refractive outcome. For best outcomes, he stressed the importance of addressing the 5 “Cs”—cylinder and residual refractive error, capsular opacities, cornea and ocular surface disease, cystoid macular edema, and centration of the IOL. “Once I started looking into these factors more closely, not just postoperatively but perioperatively, I find that I am able to address many of CALENDAR OF MEETINGS 2015 these conditions quite appropriately,” Dr. Ramamurthy said. Addressing these five factors can enhance outcomes and improve patient satisfaction, but in the end, patients are more concerned about how much you care, rather than how much you know, he said. When patients are unhappy with their refractive outcomes, be sure to acknowledge their dissatisfaction, Dr. Ramamurthy said. EWAP Editors’ note: Dr. Donnenfeld has financial interests with AMO. Dr. Gatinel co-designed the FineVision lens. Dr. Morselli has financial interests with B+L. Dr. Ramamurthy has no financial interests related to his comments. Contact information Donnenfeld: ericdonnenfeld@gmail.com Gatinel: gatinel@gmail.com Morselli: morsell@tiscali.it Ramamurthy: info@theeyefoundation.com DATE MEETING VENUE April 17-21 ASCRS-ASOA Symposium & Congress www.ascrs.org San Diego USA May 22-25 25th SNEC Anniversary Meeting www.snec.com.sg Singapore July 19-21 30th Annual Meeting of Japanese Society of Cataract & Refractive Surgery (JSCRS) www.jscrs.org Tokyo Japan August 5-8 28th Asia-Paci c Association of Cataract and Refractive Surgeons Annual Meeting (APACRS) www.apacrs.org Kuala Lumpur Malaysia September 5-9 XXXIII Congress of European Society of Cataract & Refractive Surgery (ESCRS) www.escrs.org Barcelona Span November 14-17 Annual Meeting of American Academy of Ophthalmology (AAO) www.aao.org Las Vegas USA